Uncompromising focus, innovation-driven manufacturing
excellence and dedication to customer satisfaction have raised
Marle amongst the top three global contract manufacturers for
orthopaedic implants.
- 100 M €
turnover - 6.5 M € annual investment
- 33,000 m2 (355.209 sq.ft) production facilities
- 600 employees
- 1.3 million implants produced a year
Versatile manufacturing technologies
Marle serves the orthopaedic industry leaders with comprehensive manufacturing capabilities to help them market implants with the highest quality, within the shortest timeframe.
Comprehensive
orthopaedics expertise
Expertise, experience and versatility
enable our teams to manufacture any
orthopaedic implant within the strictest deadlines,
budgets and technical demands.
Our site Etablissements Maurice Marle in Nogent (52800) was selected from 1750 candidates to represent the department of Haute-Marne, during the Great Exhibition of Made in France.
Marle Group to exhibit for the first time in China, for the 14th Annual Congress of Chinese Orthopaedic Association, in Shanghai, from 15th to 17th November 2019.
DENTRESSANGLE, the family-investment holding company, has entered into exclusive negotiations to acquire a majority stake in MARLE.